| September 01, 2026 | |
A significant number of men who undergo prostatic artery embolization (PAE) as their first procedure for benign prostatic hyperplasia (BPH) may eventually require reintervention.
A new paper in the Journal of Vascular and Interventional Radiology describes reintervention rates of men with BPH in the years following PAE. According to the data, as many as 25% of these men will require additional treatment within five years of their first intervention. The new data provide valuable insight into outcomes that are not yet well described, authors of the paper contend.
“Published reintervention estimates after PAE have ranged from approximately 16%–51% at 40 years; this wide range reflects differing endpoint definitions (for example, whether medical treatment, repeat PAE, or specific surgical modalities are counted) as well as potential differences in durability, and derive predominantly from single-center series or international registries with limited generalizability to U.S. practice patterns,” writes Tarub S. Mabud MD, MSc, with the division of vascular and interventional radiology at Columbia University Irving Medical Center in New York. “The durability of PAE in routine U.S. practice, outside of high-volume academic centers and protocolized trials, remains less well characterized.”
No comments:
Post a Comment